SEC Form 4 · accession 0001209191-17-037768
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick W Ahlholm
Officer — SVP, Chief Accounting Officer
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | M | 14,381 | $5.19 | A | 19,381 | D | |
| Common Stock | Jun 1, 2017 | M | 7,250 | $4.71 | A | 26,631 | D | |
| Common Stock | Jun 1, 2017 | S | 11,250 | $10.00 | D | 15,381 | D | |
| Common Stock | Jun 1, 2017 | S | 10,381 | $11.00 | D | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $5.19 | Jun 1, 2017 | M | 14,381 | D | — | Apr 13, 2025 | Common Stock | 14,381 | 43,143 | D |
| Employee Stock Option (Right to Buy)F3 | $4.71 | Jun 1, 2017 | M | 7,250 | D | — | Dec 3, 2025 | Common Stock | 7,250 | 49,750 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2016.
- F2This option vested as to 25% of the shares on April 14, 2016 and then in quarterly installments over 3 years thereafter.
- F3This option vested as to 25% of the shares on December 4, 2016 and then in quarterly installments over 3 years thereafter.